终结丙型肝炎病毒之路的开端：第 26 届丙型肝炎病毒及相关病毒国际研讨会综述。
The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses.
机构信息
Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea.
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
出版信息
Viruses. 2020 Mar 11;12(3):302. doi: 10.3390/v12030302.
Hepatitis C virus (HCV) infects ~71 million people worldwide, and 399,000 people die annually due to HCV-related liver cirrhosis and hepatocellular carcinoma. The use of direct-acting antivirals results in a sustained virologic response in >95% of patients with chronic HCV infection. However, several issues remain to be solved to eradicate HCV. At the 26th International Symposium on Hepatitis C Virus and Related Viruses (HCV2019) held in Seoul, South Korea, October 5-8, 2019, virologists, immunologists, and clinical scientists discussed these remaining issues and how we can achieve the elimination of HCV.
丙型肝炎病毒（HCV）感染全球约 7100 万人，每年有 39.9 万人因 HCV 相关的肝硬化和肝细胞癌而死亡。直接作用抗病毒药物的使用使超过 95%的慢性 HCV 感染者获得持续病毒学应答。然而，要消灭 HCV，仍有一些问题需要解决。在 2019 年 10 月 5 日至 8 日于韩国首尔举行的第 26 届丙型肝炎病毒和相关病毒国际研讨会（HCV2019）上，病毒学家、免疫学家和临床科学家讨论了这些遗留问题以及我们如何实现消灭 HCV。
Zotero 插件